2016
DOI: 10.1182/blood.v128.22.5331.5331
|View full text |Cite
|
Sign up to set email alerts
|

Rituximab Maintenance for Advanced Follicular Lymphoma (FL) Patients - Comparison of Outcomes after First and Second Line Treatment in a Single Center Series

Abstract: Standard approach to advanced stage FL patients in need of treatment is immunochemotherapy followed by rituximab maintenance (RM). Maintenance improves disease control after first line and overall survival in the relapse setting. The relative benefits of maintenance after first or subsequent treatment have not been directly compared. Purpose: To compare the clinical outcome of patients receiving RM after first-line treatment with those who received RM for the first time after second line. … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles